OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired
Hany E. Marei, Anwarul Hasan, Giacomo Pozzoli, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 107
Hany E. Marei, Anwarul Hasan, Giacomo Pozzoli, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 107
Showing 1-25 of 107 citing articles:
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 16
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 16
Insights into the Tumor Microenvironment—Components, Functions and Therapeutics
Kornélia Baghy, Andrea Ladányi, Andrea Reszegi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17536-17536
Open Access | Times Cited: 27
Kornélia Baghy, Andrea Ladányi, Andrea Reszegi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17536-17536
Open Access | Times Cited: 27
Immunomodulatory Precision: A Narrative Review Exploring the Critical Role of Immune Checkpoint Inhibitors in Cancer Treatment
Junyu Qiu, Zilin Cheng, Zheng Jiang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5490-5490
Open Access | Times Cited: 13
Junyu Qiu, Zilin Cheng, Zheng Jiang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5490-5490
Open Access | Times Cited: 13
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines
Valentina Zanrè, Francesco Bellinato, Alessia Cardile, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1615-1615
Open Access | Times Cited: 10
Valentina Zanrè, Francesco Bellinato, Alessia Cardile, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1615-1615
Open Access | Times Cited: 10
Cardiovascular toxicity of immune therapies for cancer
Nicolas L. Palaskas, Hyeon-Ju Ali, Efstratios Koutroumpakis, et al.
BMJ (2024), pp. e075859-e075859
Closed Access | Times Cited: 8
Nicolas L. Palaskas, Hyeon-Ju Ali, Efstratios Koutroumpakis, et al.
BMJ (2024), pp. e075859-e075859
Closed Access | Times Cited: 8
Global research trends and emerging hotspots in nano-drug delivery systems for lung cancer: a comprehensive bibliometric analysis (1998–2024)
Yu Cao, Chunhai Fan, Y. Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Yu Cao, Chunhai Fan, Y. Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Demystifying the Role of Immuno PET-CT in Non-Small Cell Lung Cancer: Clinical Value and Research Trends
Sobhan Vinjamuri, Vineet Pant
Seminars in Nuclear Medicine (2025)
Closed Access | Times Cited: 1
Sobhan Vinjamuri, Vineet Pant
Seminars in Nuclear Medicine (2025)
Closed Access | Times Cited: 1
Immune check point inhibitors for ocular adnexal and periocular tumors
Palwasha Syar, Sara Moussavi, Carlos Torres-Caballa, et al.
Taiwan Journal of Ophthalmology (2025) Vol. 15, Iss. 1, pp. 14-25
Open Access | Times Cited: 1
Palwasha Syar, Sara Moussavi, Carlos Torres-Caballa, et al.
Taiwan Journal of Ophthalmology (2025) Vol. 15, Iss. 1, pp. 14-25
Open Access | Times Cited: 1
Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective
Yunyi Wu, Yanchun Li, Yan Gao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116132-116132
Open Access | Times Cited: 7
Yunyi Wu, Yanchun Li, Yan Gao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116132-116132
Open Access | Times Cited: 7
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit
Kourtney L. Kostecki, Mari Iida, Bridget E. Crossman, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 312-312
Open Access | Times Cited: 6
Kourtney L. Kostecki, Mari Iida, Bridget E. Crossman, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 312-312
Open Access | Times Cited: 6
Phenylboronic acid-functionalized biomaterials for improved cancer immunotherapy via sialic acid targeting
Ashok Kumar Jangid, Kyobum Kim
Advances in Colloid and Interface Science (2024) Vol. 333, pp. 103301-103301
Closed Access | Times Cited: 5
Ashok Kumar Jangid, Kyobum Kim
Advances in Colloid and Interface Science (2024) Vol. 333, pp. 103301-103301
Closed Access | Times Cited: 5
Association of thrombocytopenia with immune checkpoint inhibitors: a large-scale pharmacovigilance analysis based on the data from FDA adverse event reporting system database
G. Liu, Shuxian Zhang, Zhuang Mo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
G. Liu, Shuxian Zhang, Zhuang Mo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Hotspots evolution and frontiers of immunotherapy for the treatment of acute myeloid leukemia: A bibliometric analysis
Nana Zhe, Qiang Li, Nanqu Huang, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Nana Zhe, Qiang Li, Nanqu Huang, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
What should intensivists know about immune checkpoint inhibitors and their side effects?
В. Г. Александров, F. Martínez Sagasti, J.A Ruíz Moreno, et al.
Medicina Intensiva (English Edition) (2025), pp. 502135-502135
Closed Access
В. Г. Александров, F. Martínez Sagasti, J.A Ruíz Moreno, et al.
Medicina Intensiva (English Edition) (2025), pp. 502135-502135
Closed Access
TMBocelot: an omnibus statistical control model optimizing the TMB thresholds with systematic measurement errors
Xin Lai, Shaoliang Wang, Xuanping Zhang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Xin Lai, Shaoliang Wang, Xuanping Zhang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Recent advancement in molecular tools for breast cancer diagnosis and therapy decision: Trends in future perspective
Riya Sharma, Priyanka Naithani, Pallavi Sharma, et al.
Elsevier eBooks (2025), pp. 113-130
Closed Access
Riya Sharma, Priyanka Naithani, Pallavi Sharma, et al.
Elsevier eBooks (2025), pp. 113-130
Closed Access
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD 73/anti‐PD ‐L 1 immunotherapy in arm A of the NSGO ‐OV ‐UMB1 /ENGOT ‐OV 30 trial
Luka Tandarić, Annika Auranen, Katrin Kleinmanns, et al.
Molecular Oncology (2025)
Open Access
Luka Tandarić, Annika Auranen, Katrin Kleinmanns, et al.
Molecular Oncology (2025)
Open Access
Identification of inflammation-related genes signature to establish a prognostic model in MGMT unmethylated glioblastoma patients
Yunzhao Mo, Dandan Fan, Weimin Wang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Yunzhao Mo, Dandan Fan, Weimin Wang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Efficacy and safety of radiotherapy in patients with microsatellite stable or proficient mismatch repair colorectal cancer liver metastasis
Jie Ni, C. W. Wan, Ziqi Sui
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access
Jie Ni, C. W. Wan, Ziqi Sui
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access
Novel Therapeutic Strategies and Recent Advances in Gut Microbiota Synergy with Nanotechnology for Colorectal Cancer Treatment
Qinghe Han, Jie Li, Zhuo Li, et al.
Materials Today Bio (2025) Vol. 31, pp. 101601-101601
Open Access
Qinghe Han, Jie Li, Zhuo Li, et al.
Materials Today Bio (2025) Vol. 31, pp. 101601-101601
Open Access
Epigenetic drugs in cancer therapy
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
PTEN-Mediated Resistance in Cancer: From Foundation to Future Therapies
Muhammad Tufail
Toxicology Reports (2025) Vol. 14, pp. 101987-101987
Open Access
Muhammad Tufail
Toxicology Reports (2025) Vol. 14, pp. 101987-101987
Open Access
Development and validation of prognostic and diagnostic models utilizing immune checkpoint-related genes in public datasets for clear cell renal cell carcinoma
Bin Zhao, Shi Fu, Yuanlong Shi, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Bin Zhao, Shi Fu, Yuanlong Shi, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment
Yuze Zhao, Yuguang Song, Weiping Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Yuze Zhao, Yuguang Song, Weiping Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
